Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Intressa Vascular

Request full access

Multilayer braided stents for treating aortic dissection

Gembloux, BelgiumFounded 1998Health Tech & Medtech

About Intressa Vascular

Intressa Vascular SA, formerly known as Cardiatis SA, is a clinical-stage MedTech company based in Gembloux, Belgium, that provides solutions for life-threatening cardiovascular conditions. Founded in 1998, the company has developed a proprietary braiding technology platform to produce multilayer stents.

The company's lead product is the Allay™ Aortic Stent, a treatment for Type B aortic dissections (TBAD) and residual dissections. This device is designed to recentralize blood flow within the aorta's true lumen, securing the dissection flap against the aortic wall while preserving blood flow to critical branch arteries through its porous, open-cell design. A key benefit is its availability as a ready-to-treat stent, which minimizes delays associated with customization and is supported by sizing software for personalized procedural planning. The goal is to offer a streamlined, minimally invasive procedure with a low risk of complications like paraplegia or stroke.

Intressa Vascular targets the endovascular treatment market for aortic dissection, an addressable segment estimated at €1.8 to €2.3 billion. The company's business model centers on developing and bringing this patented technology to market, with revenue expected from the sale of the Allay® Aortic Stent to specialized aortic treatment centers. The company is actively engaged in clinical trials, such as the DRAGON and EXTENSO studies, to validate the safety and efficacy of its device and support product registration in key markets, including the USA, Europe, and China.

Between 2021 and 2023, the company secured significant financing totaling €31 million through a combination of equity rounds and non-dilutive funding to advance its clinical development and product registration. Key investors include Noshaq, Yonjin Capital, the White Fund, and SRIW, with additional support from the Walloon Region. The leadership team, led by CEO Pierre Douette and CSO Diane Lejeune, possesses extensive experience in medical technology, clinical affairs, and regulatory strategy.

Source: Dealroom company data

At a glance

Status
Operational
Employees
23
Open positions
None listed
Dealroom signal
38.3/100
Industry
Health
Sub-industry
Medical Devices
Sector
medical implants, Cardiology and cardiovascular, Chronic Disease, Sustainable Development Goals, biotech medtech and e-health, DT and LS, science-based
Technology
Deep Tech
Business model
Manufacturing
Client focus
B2B

Funding history

6 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
DEBTDebt Oct 2023 $3.3M — Undisclosed ↗
LATE VCOther financing Oct 2023 $11M $66M CPH Banque · White fund · Yonjin Venture · Noshaq ↗
Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

Intressa Vascular website traffic

Latest recorded traffic for Intressa Vascular is 630 monthly website visits, up 350% over the last three months. Intressa Vascular's team grew 4.5% over the past year.

Latest monthly visits630 3-month web change+350% 1-year team growth+4.5%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Intressa Vascular in the Gembloux ecosystem

Live from Dealroom

The Intressa Vascular office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • Walloon Region

Series B and later5 investors entered at this stage

  • White fund
  • Wallonie Entreprendre
  • Yonjin Venture
  • Noshaq
  • CPH Banque
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

See Intressa Vascular’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.